Mortality from angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers in people infected with COVID-19: a cohort study of 3.7 million people
dc.contributor.author | Dambha-Miller, H | en_US |
dc.contributor.author | Hinton, W | en_US |
dc.contributor.author | Wilcox, CR | en_US |
dc.contributor.author | Lemanska, A | en_US |
dc.contributor.author | Joy, M | en_US |
dc.contributor.author | Feher, M | en_US |
dc.contributor.author | Stuart, B | en_US |
dc.contributor.author | de Lusignan, S | en_US |
dc.contributor.author | Hippisley-Cox, J | en_US |
dc.contributor.author | Griffin, S | en_US |
dc.date.accessioned | 2023-01-10T14:57:04Z | |
dc.date.issued | 2023 | en_US |
dc.identifier.issn | 0263-2136 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/83632 | |
dc.format.extent | 330 - 337 | en_US |
dc.relation.ispartof | FAMILY PRACTICE | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | mortality | en_US |
dc.subject | medication | en_US |
dc.title | Mortality from angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers in people infected with COVID-19: a cohort study of 3.7 million people | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1093/fampra/cmac094 | en_US |
pubs.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000843993100001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 2 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 40 | en_US |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |